nodes	percent_of_prediction	percent_of_DWPC	metapath
Praziquantel—CYP3A43—Dexamethasone—hematologic cancer	0.0517	0.0675	CbGbCtD
Praziquantel—CYP1A2—Anagrelide—hematologic cancer	0.0329	0.0429	CbGbCtD
Praziquantel—CYP3A7—Ifosfamide—hematologic cancer	0.0192	0.0251	CbGbCtD
Praziquantel—CYP3A7-CYP3A51P—Ifosfamide—hematologic cancer	0.0192	0.0251	CbGbCtD
Praziquantel—CYP3A7—Imatinib—hematologic cancer	0.0183	0.0239	CbGbCtD
Praziquantel—CYP3A7-CYP3A51P—Imatinib—hematologic cancer	0.0183	0.0239	CbGbCtD
Praziquantel—CYP3A5—Daunorubicin—hematologic cancer	0.0179	0.0234	CbGbCtD
Praziquantel—CYP2D6—Lomustine—hematologic cancer	0.0174	0.0228	CbGbCtD
Praziquantel—CYP1A2—Carmustine—hematologic cancer	0.0173	0.0225	CbGbCtD
Praziquantel—CYP3A5—Thalidomide—hematologic cancer	0.0163	0.0213	CbGbCtD
Praziquantel—CYP3A5—Teniposide—hematologic cancer	0.0156	0.0204	CbGbCtD
Praziquantel—CYP2D6—Idarubicin—hematologic cancer	0.0155	0.0203	CbGbCtD
Praziquantel—CYP2C19—Bortezomib—hematologic cancer	0.0151	0.0198	CbGbCtD
Praziquantel—CYP1A2—Methoxsalen—hematologic cancer	0.0147	0.0192	CbGbCtD
Praziquantel—CYP3A5—Ifosfamide—hematologic cancer	0.0144	0.0188	CbGbCtD
Praziquantel—CYP1A2—Bortezomib—hematologic cancer	0.014	0.0182	CbGbCtD
Praziquantel—CYP3A5—Imatinib—hematologic cancer	0.0137	0.018	CbGbCtD
Praziquantel—CYP1A2—Daunorubicin—hematologic cancer	0.0134	0.0174	CbGbCtD
Praziquantel—CYP2D6—Hydroxyurea—hematologic cancer	0.0132	0.0173	CbGbCtD
Praziquantel—CYP2C19—Thalidomide—hematologic cancer	0.0132	0.0172	CbGbCtD
Praziquantel—CYP1A2—Alitretinoin—hematologic cancer	0.0131	0.0171	CbGbCtD
Praziquantel—CYP2C19—Teniposide—hematologic cancer	0.0126	0.0164	CbGbCtD
Praziquantel—CYP1A2—Thalidomide—hematologic cancer	0.0122	0.0159	CbGbCtD
Praziquantel—CYP3A4—Bexarotene—hematologic cancer	0.0119	0.0156	CbGbCtD
Praziquantel—CYP2C19—Ifosfamide—hematologic cancer	0.0116	0.0152	CbGbCtD
Praziquantel—CYP2D6—Bortezomib—hematologic cancer	0.0115	0.015	CbGbCtD
Praziquantel—CYP3A7—Irinotecan—hematologic cancer	0.0114	0.0149	CbGbCtD
Praziquantel—CYP3A7-CYP3A51P—Irinotecan—hematologic cancer	0.0114	0.0149	CbGbCtD
Praziquantel—CYP3A4—Busulfan—hematologic cancer	0.0111	0.0145	CbGbCtD
Praziquantel—CYP3A4—Lomustine—hematologic cancer	0.0111	0.0145	CbGbCtD
Praziquantel—CYP2C19—Imatinib—hematologic cancer	0.0111	0.0145	CbGbCtD
Praziquantel—CYP3A5—Dasatinib—hematologic cancer	0.011	0.0144	CbGbCtD
Praziquantel—CYP1A2—Dacarbazine—hematologic cancer	0.0105	0.0137	CbGbCtD
Praziquantel—CYP1A2—Imatinib—hematologic cancer	0.0102	0.0134	CbGbCtD
Praziquantel—CYP3A7—Vincristine—hematologic cancer	0.01	0.0131	CbGbCtD
Praziquantel—CYP3A7-CYP3A51P—Vincristine—hematologic cancer	0.01	0.0131	CbGbCtD
Praziquantel—CYP3A4—Thiotepa—hematologic cancer	0.00989	0.0129	CbGbCtD
Praziquantel—CYP3A5—Irinotecan—hematologic cancer	0.00858	0.0112	CbGbCtD
Praziquantel—CYP2D6—Imatinib—hematologic cancer	0.00843	0.011	CbGbCtD
Praziquantel—CYP1A2—Dasatinib—hematologic cancer	0.00821	0.0107	CbGbCtD
Praziquantel—CYP3A4—Methoxsalen—hematologic cancer	0.00769	0.01	CbGbCtD
Praziquantel—CYP2D6—Nilotinib—hematologic cancer	0.00766	0.01	CbGbCtD
Praziquantel—CYP2D6—Vinorelbine—hematologic cancer	0.00759	0.00992	CbGbCtD
Praziquantel—CYP3A7-CYP3A51P—Dexamethasone—hematologic cancer	0.00753	0.00984	CbGbCtD
Praziquantel—CYP3A7—Dexamethasone—hematologic cancer	0.00753	0.00984	CbGbCtD
Praziquantel—CYP3A5—Vincristine—hematologic cancer	0.0075	0.0098	CbGbCtD
Praziquantel—CYP3A4—Bortezomib—hematologic cancer	0.00731	0.00955	CbGbCtD
Praziquantel—CYP2C19—Prednisone—hematologic cancer	0.0073	0.00954	CbGbCtD
Praziquantel—CYP3A4—Daunorubicin—hematologic cancer	0.00699	0.00914	CbGbCtD
Praziquantel—CYP3A5—Etoposide—hematologic cancer	0.00687	0.00898	CbGbCtD
Praziquantel—CYP3A4—Cytarabine—hematologic cancer	0.00617	0.00806	CbGbCtD
Praziquantel—CYP3A4—Teniposide—hematologic cancer	0.00608	0.00794	CbGbCtD
Praziquantel—CYP3A5—Dexamethasone—hematologic cancer	0.00565	0.00738	CbGbCtD
Praziquantel—CYP3A4—Ifosfamide—hematologic cancer	0.00561	0.00733	CbGbCtD
Praziquantel—CYP3A4—Imatinib—hematologic cancer	0.00536	0.007	CbGbCtD
Praziquantel—CYP1A2—Etoposide—hematologic cancer	0.00512	0.00668	CbGbCtD
Praziquantel—CYP3A4—Ruxolitinib—hematologic cancer	0.00505	0.00659	CbGbCtD
Praziquantel—CYP3A4—Nilotinib—hematologic cancer	0.00487	0.00636	CbGbCtD
Praziquantel—CYP3A4—Vinorelbine—hematologic cancer	0.00483	0.00631	CbGbCtD
Praziquantel—CYP2D6—Vinblastine—hematologic cancer	0.00468	0.00611	CbGbCtD
Praziquantel—CYP2C19—Dexamethasone—hematologic cancer	0.00456	0.00596	CbGbCtD
Praziquantel—CYP3A4—Triamcinolone—hematologic cancer	0.00442	0.00577	CbGbCtD
Praziquantel—CYP3A4—Dasatinib—hematologic cancer	0.0043	0.00562	CbGbCtD
Praziquantel—CYP3A4—Mitoxantrone—hematologic cancer	0.00425	0.00555	CbGbCtD
Praziquantel—CYP3A4—Betamethasone—hematologic cancer	0.00379	0.00495	CbGbCtD
Praziquantel—CYP3A4—Prednisolone—hematologic cancer	0.00374	0.00488	CbGbCtD
Praziquantel—CYP3A4—Prednisone—hematologic cancer	0.00353	0.00461	CbGbCtD
Praziquantel—CYP2D6—Dexamethasone—hematologic cancer	0.00347	0.00453	CbGbCtD
Praziquantel—CYP3A4—Irinotecan—hematologic cancer	0.00335	0.00437	CbGbCtD
Praziquantel—CYP3A4—Vinblastine—hematologic cancer	0.00298	0.00389	CbGbCtD
Praziquantel—CYP3A4—Vincristine—hematologic cancer	0.00293	0.00382	CbGbCtD
Praziquantel—CYP2D6—Doxorubicin—hematologic cancer	0.00288	0.00376	CbGbCtD
Praziquantel—CYP3A4—Etoposide—hematologic cancer	0.00268	0.0035	CbGbCtD
Praziquantel—CYP3A4—Dexamethasone—hematologic cancer	0.0022	0.00288	CbGbCtD
Praziquantel—CYP3A4—Doxorubicin—hematologic cancer	0.00183	0.00239	CbGbCtD
Praziquantel—Diarrhoea—Irinotecan—hematologic cancer	9.63e-05	0.000453	CcSEcCtD
Praziquantel—Vomiting—Carmustine—hematologic cancer	9.63e-05	0.000453	CcSEcCtD
Praziquantel—Gastrointestinal pain—Etoposide—hematologic cancer	9.58e-05	0.00045	CcSEcCtD
Praziquantel—Dizziness—Vincristine—hematologic cancer	9.56e-05	0.000449	CcSEcCtD
Praziquantel—Rash—Carmustine—hematologic cancer	9.55e-05	0.000449	CcSEcCtD
Praziquantel—Ill-defined disorder—Prednisone—hematologic cancer	9.54e-05	0.000448	CcSEcCtD
Praziquantel—Dermatitis—Carmustine—hematologic cancer	9.54e-05	0.000448	CcSEcCtD
Praziquantel—Vomiting—Alitretinoin—hematologic cancer	9.54e-05	0.000448	CcSEcCtD
Praziquantel—Drowsiness—Doxorubicin—hematologic cancer	9.52e-05	0.000448	CcSEcCtD
Praziquantel—Feeling abnormal—Prednisolone—hematologic cancer	9.52e-05	0.000447	CcSEcCtD
Praziquantel—Headache—Carmustine—hematologic cancer	9.49e-05	0.000446	CcSEcCtD
Praziquantel—Rash—Alitretinoin—hematologic cancer	9.46e-05	0.000445	CcSEcCtD
Praziquantel—Nervous system disorder—Dexamethasone—hematologic cancer	9.45e-05	0.000444	CcSEcCtD
Praziquantel—Nervous system disorder—Betamethasone—hematologic cancer	9.45e-05	0.000444	CcSEcCtD
Praziquantel—Dermatitis—Alitretinoin—hematologic cancer	9.45e-05	0.000444	CcSEcCtD
Praziquantel—Vomiting—Ifosfamide—hematologic cancer	9.43e-05	0.000443	CcSEcCtD
Praziquantel—Hypersensitivity—Cisplatin—hematologic cancer	9.42e-05	0.000443	CcSEcCtD
Praziquantel—Bradycardia—Epirubicin—hematologic cancer	9.41e-05	0.000442	CcSEcCtD
Praziquantel—Headache—Alitretinoin—hematologic cancer	9.4e-05	0.000442	CcSEcCtD
Praziquantel—Diarrhoea—Gemcitabine—hematologic cancer	9.38e-05	0.000441	CcSEcCtD
Praziquantel—Nausea—Thalidomide—hematologic cancer	9.37e-05	0.00044	CcSEcCtD
Praziquantel—Rash—Ifosfamide—hematologic cancer	9.35e-05	0.000439	CcSEcCtD
Praziquantel—Dermatitis—Ifosfamide—hematologic cancer	9.34e-05	0.000439	CcSEcCtD
Praziquantel—Dizziness—Irinotecan—hematologic cancer	9.31e-05	0.000438	CcSEcCtD
Praziquantel—Urticaria—Etoposide—hematologic cancer	9.3e-05	0.000437	CcSEcCtD
Praziquantel—Malaise—Prednisone—hematologic cancer	9.27e-05	0.000436	CcSEcCtD
Praziquantel—Body temperature increased—Etoposide—hematologic cancer	9.26e-05	0.000435	CcSEcCtD
Praziquantel—Abdominal pain—Etoposide—hematologic cancer	9.26e-05	0.000435	CcSEcCtD
Praziquantel—Vertigo—Prednisone—hematologic cancer	9.24e-05	0.000434	CcSEcCtD
Praziquantel—Vomiting—Vincristine—hematologic cancer	9.19e-05	0.000432	CcSEcCtD
Praziquantel—Anorexia—Betamethasone—hematologic cancer	9.19e-05	0.000432	CcSEcCtD
Praziquantel—Anorexia—Dexamethasone—hematologic cancer	9.19e-05	0.000432	CcSEcCtD
Praziquantel—Urticaria—Prednisolone—hematologic cancer	9.18e-05	0.000431	CcSEcCtD
Praziquantel—Asthenia—Cisplatin—hematologic cancer	9.17e-05	0.000431	CcSEcCtD
Praziquantel—Cardiac disorder—Methotrexate—hematologic cancer	9.16e-05	0.000431	CcSEcCtD
Praziquantel—Fatigue—Triamcinolone—hematologic cancer	9.16e-05	0.00043	CcSEcCtD
Praziquantel—Rash—Vincristine—hematologic cancer	9.11e-05	0.000428	CcSEcCtD
Praziquantel—Dermatitis—Vincristine—hematologic cancer	9.11e-05	0.000428	CcSEcCtD
Praziquantel—Headache—Vincristine—hematologic cancer	9.06e-05	0.000426	CcSEcCtD
Praziquantel—Nausea—Carmustine—hematologic cancer	8.99e-05	0.000423	CcSEcCtD
Praziquantel—Vomiting—Irinotecan—hematologic cancer	8.95e-05	0.000421	CcSEcCtD
Praziquantel—Vomiting—Mitoxantrone—hematologic cancer	8.95e-05	0.000421	CcSEcCtD
Praziquantel—Immune system disorder—Methotrexate—hematologic cancer	8.92e-05	0.000419	CcSEcCtD
Praziquantel—Nausea—Alitretinoin—hematologic cancer	8.91e-05	0.000419	CcSEcCtD
Praziquantel—Convulsion—Prednisone—hematologic cancer	8.91e-05	0.000419	CcSEcCtD
Praziquantel—Rash—Irinotecan—hematologic cancer	8.88e-05	0.000417	CcSEcCtD
Praziquantel—Rash—Mitoxantrone—hematologic cancer	8.88e-05	0.000417	CcSEcCtD
Praziquantel—Dermatitis—Mitoxantrone—hematologic cancer	8.87e-05	0.000417	CcSEcCtD
Praziquantel—Dermatitis—Irinotecan—hematologic cancer	8.87e-05	0.000417	CcSEcCtD
Praziquantel—Headache—Mitoxantrone—hematologic cancer	8.82e-05	0.000415	CcSEcCtD
Praziquantel—Headache—Irinotecan—hematologic cancer	8.82e-05	0.000415	CcSEcCtD
Praziquantel—Nausea—Ifosfamide—hematologic cancer	8.81e-05	0.000414	CcSEcCtD
Praziquantel—Musculoskeletal discomfort—Betamethasone—hematologic cancer	8.78e-05	0.000413	CcSEcCtD
Praziquantel—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	8.78e-05	0.000413	CcSEcCtD
Praziquantel—Myalgia—Prednisone—hematologic cancer	8.76e-05	0.000411	CcSEcCtD
Praziquantel—Feeling abnormal—Triamcinolone—hematologic cancer	8.75e-05	0.000411	CcSEcCtD
Praziquantel—Diarrhoea—Cisplatin—hematologic cancer	8.75e-05	0.000411	CcSEcCtD
Praziquantel—Vomiting—Gemcitabine—hematologic cancer	8.72e-05	0.00041	CcSEcCtD
Praziquantel—Bradycardia—Doxorubicin—hematologic cancer	8.7e-05	0.000409	CcSEcCtD
Praziquantel—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	8.69e-05	0.000409	CcSEcCtD
Praziquantel—Discomfort—Prednisone—hematologic cancer	8.65e-05	0.000407	CcSEcCtD
Praziquantel—Rash—Gemcitabine—hematologic cancer	8.65e-05	0.000406	CcSEcCtD
Praziquantel—Dermatitis—Gemcitabine—hematologic cancer	8.64e-05	0.000406	CcSEcCtD
Praziquantel—Hypersensitivity—Etoposide—hematologic cancer	8.63e-05	0.000405	CcSEcCtD
Praziquantel—Headache—Gemcitabine—hematologic cancer	8.59e-05	0.000404	CcSEcCtD
Praziquantel—Nausea—Vincristine—hematologic cancer	8.59e-05	0.000404	CcSEcCtD
Praziquantel—Cardiac disorder—Epirubicin—hematologic cancer	8.57e-05	0.000403	CcSEcCtD
Praziquantel—Hypersensitivity—Prednisolone—hematologic cancer	8.51e-05	0.0004	CcSEcCtD
Praziquantel—Urticaria—Triamcinolone—hematologic cancer	8.44e-05	0.000397	CcSEcCtD
Praziquantel—Asthenia—Etoposide—hematologic cancer	8.4e-05	0.000395	CcSEcCtD
Praziquantel—Body temperature increased—Triamcinolone—hematologic cancer	8.4e-05	0.000395	CcSEcCtD
Praziquantel—Decreased appetite—Dexamethasone—hematologic cancer	8.38e-05	0.000394	CcSEcCtD
Praziquantel—Decreased appetite—Betamethasone—hematologic cancer	8.38e-05	0.000394	CcSEcCtD
Praziquantel—Nausea—Mitoxantrone—hematologic cancer	8.36e-05	0.000393	CcSEcCtD
Praziquantel—Nausea—Irinotecan—hematologic cancer	8.36e-05	0.000393	CcSEcCtD
Praziquantel—Immune system disorder—Epirubicin—hematologic cancer	8.35e-05	0.000392	CcSEcCtD
Praziquantel—Gastrointestinal disorder—Dexamethasone—hematologic cancer	8.32e-05	0.000391	CcSEcCtD
Praziquantel—Gastrointestinal disorder—Betamethasone—hematologic cancer	8.32e-05	0.000391	CcSEcCtD
Praziquantel—Fatigue—Dexamethasone—hematologic cancer	8.31e-05	0.000391	CcSEcCtD
Praziquantel—Fatigue—Betamethasone—hematologic cancer	8.31e-05	0.000391	CcSEcCtD
Praziquantel—Pruritus—Etoposide—hematologic cancer	8.28e-05	0.000389	CcSEcCtD
Praziquantel—Arrhythmia—Epirubicin—hematologic cancer	8.25e-05	0.000388	CcSEcCtD
Praziquantel—Nervous system disorder—Prednisone—hematologic cancer	8.23e-05	0.000387	CcSEcCtD
Praziquantel—Skin disorder—Prednisone—hematologic cancer	8.15e-05	0.000383	CcSEcCtD
Praziquantel—Nausea—Gemcitabine—hematologic cancer	8.15e-05	0.000383	CcSEcCtD
Praziquantel—Vomiting—Cisplatin—hematologic cancer	8.13e-05	0.000382	CcSEcCtD
Praziquantel—Rash—Cisplatin—hematologic cancer	8.06e-05	0.000379	CcSEcCtD
Praziquantel—Dermatitis—Cisplatin—hematologic cancer	8.05e-05	0.000378	CcSEcCtD
Praziquantel—Diarrhoea—Etoposide—hematologic cancer	8.01e-05	0.000377	CcSEcCtD
Praziquantel—Anorexia—Prednisone—hematologic cancer	8e-05	0.000376	CcSEcCtD
Praziquantel—Ill-defined disorder—Methotrexate—hematologic cancer	7.97e-05	0.000375	CcSEcCtD
Praziquantel—Feeling abnormal—Betamethasone—hematologic cancer	7.94e-05	0.000373	CcSEcCtD
Praziquantel—Feeling abnormal—Dexamethasone—hematologic cancer	7.94e-05	0.000373	CcSEcCtD
Praziquantel—Cardiac disorder—Doxorubicin—hematologic cancer	7.93e-05	0.000373	CcSEcCtD
Praziquantel—Gastrointestinal pain—Betamethasone—hematologic cancer	7.88e-05	0.00037	CcSEcCtD
Praziquantel—Gastrointestinal pain—Dexamethasone—hematologic cancer	7.88e-05	0.00037	CcSEcCtD
Praziquantel—Hypersensitivity—Triamcinolone—hematologic cancer	7.83e-05	0.000368	CcSEcCtD
Praziquantel—Malaise—Methotrexate—hematologic cancer	7.75e-05	0.000364	CcSEcCtD
Praziquantel—Dizziness—Etoposide—hematologic cancer	7.74e-05	0.000364	CcSEcCtD
Praziquantel—Immune system disorder—Doxorubicin—hematologic cancer	7.72e-05	0.000363	CcSEcCtD
Praziquantel—Vertigo—Methotrexate—hematologic cancer	7.72e-05	0.000363	CcSEcCtD
Praziquantel—Urticaria—Betamethasone—hematologic cancer	7.66e-05	0.00036	CcSEcCtD
Praziquantel—Urticaria—Dexamethasone—hematologic cancer	7.66e-05	0.00036	CcSEcCtD
Praziquantel—Musculoskeletal discomfort—Prednisone—hematologic cancer	7.65e-05	0.000359	CcSEcCtD
Praziquantel—Dizziness—Prednisolone—hematologic cancer	7.64e-05	0.000359	CcSEcCtD
Praziquantel—Arrhythmia—Doxorubicin—hematologic cancer	7.64e-05	0.000359	CcSEcCtD
Praziquantel—Asthenia—Triamcinolone—hematologic cancer	7.62e-05	0.000358	CcSEcCtD
Praziquantel—Abdominal pain—Betamethasone—hematologic cancer	7.62e-05	0.000358	CcSEcCtD
Praziquantel—Body temperature increased—Betamethasone—hematologic cancer	7.62e-05	0.000358	CcSEcCtD
Praziquantel—Abdominal pain—Dexamethasone—hematologic cancer	7.62e-05	0.000358	CcSEcCtD
Praziquantel—Body temperature increased—Dexamethasone—hematologic cancer	7.62e-05	0.000358	CcSEcCtD
Praziquantel—Nausea—Cisplatin—hematologic cancer	7.59e-05	0.000357	CcSEcCtD
Praziquantel—Pruritus—Triamcinolone—hematologic cancer	7.51e-05	0.000353	CcSEcCtD
Praziquantel—Ill-defined disorder—Epirubicin—hematologic cancer	7.46e-05	0.000351	CcSEcCtD
Praziquantel—Convulsion—Methotrexate—hematologic cancer	7.45e-05	0.00035	CcSEcCtD
Praziquantel—Vomiting—Etoposide—hematologic cancer	7.45e-05	0.00035	CcSEcCtD
Praziquantel—Rash—Etoposide—hematologic cancer	7.38e-05	0.000347	CcSEcCtD
Praziquantel—Dermatitis—Etoposide—hematologic cancer	7.38e-05	0.000347	CcSEcCtD
Praziquantel—Headache—Etoposide—hematologic cancer	7.34e-05	0.000345	CcSEcCtD
Praziquantel—Myalgia—Methotrexate—hematologic cancer	7.32e-05	0.000344	CcSEcCtD
Praziquantel—Decreased appetite—Prednisone—hematologic cancer	7.3e-05	0.000343	CcSEcCtD
Praziquantel—Rash—Prednisolone—hematologic cancer	7.28e-05	0.000342	CcSEcCtD
Praziquantel—Dermatitis—Prednisolone—hematologic cancer	7.28e-05	0.000342	CcSEcCtD
Praziquantel—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	7.27e-05	0.000342	CcSEcCtD
Praziquantel—Malaise—Epirubicin—hematologic cancer	7.25e-05	0.000341	CcSEcCtD
Praziquantel—Fatigue—Prednisone—hematologic cancer	7.24e-05	0.00034	CcSEcCtD
Praziquantel—Headache—Prednisolone—hematologic cancer	7.24e-05	0.00034	CcSEcCtD
Praziquantel—Discomfort—Methotrexate—hematologic cancer	7.23e-05	0.00034	CcSEcCtD
Praziquantel—Vertigo—Epirubicin—hematologic cancer	7.23e-05	0.00034	CcSEcCtD
Praziquantel—Dizziness—Triamcinolone—hematologic cancer	7.02e-05	0.00033	CcSEcCtD
Praziquantel—Convulsion—Epirubicin—hematologic cancer	6.97e-05	0.000328	CcSEcCtD
Praziquantel—Nausea—Etoposide—hematologic cancer	6.96e-05	0.000327	CcSEcCtD
Praziquantel—Feeling abnormal—Prednisone—hematologic cancer	6.92e-05	0.000325	CcSEcCtD
Praziquantel—Asthenia—Betamethasone—hematologic cancer	6.91e-05	0.000325	CcSEcCtD
Praziquantel—Asthenia—Dexamethasone—hematologic cancer	6.91e-05	0.000325	CcSEcCtD
Praziquantel—Ill-defined disorder—Doxorubicin—hematologic cancer	6.9e-05	0.000325	CcSEcCtD
Praziquantel—Nervous system disorder—Methotrexate—hematologic cancer	6.88e-05	0.000323	CcSEcCtD
Praziquantel—Gastrointestinal pain—Prednisone—hematologic cancer	6.86e-05	0.000323	CcSEcCtD
Praziquantel—Nausea—Prednisolone—hematologic cancer	6.86e-05	0.000322	CcSEcCtD
Praziquantel—Myalgia—Epirubicin—hematologic cancer	6.85e-05	0.000322	CcSEcCtD
Praziquantel—Pruritus—Dexamethasone—hematologic cancer	6.82e-05	0.00032	CcSEcCtD
Praziquantel—Pruritus—Betamethasone—hematologic cancer	6.82e-05	0.00032	CcSEcCtD
Praziquantel—Skin disorder—Methotrexate—hematologic cancer	6.81e-05	0.00032	CcSEcCtD
Praziquantel—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	6.8e-05	0.00032	CcSEcCtD
Praziquantel—Discomfort—Epirubicin—hematologic cancer	6.77e-05	0.000318	CcSEcCtD
Praziquantel—Vomiting—Triamcinolone—hematologic cancer	6.75e-05	0.000317	CcSEcCtD
Praziquantel—Malaise—Doxorubicin—hematologic cancer	6.71e-05	0.000315	CcSEcCtD
Praziquantel—Rash—Triamcinolone—hematologic cancer	6.7e-05	0.000315	CcSEcCtD
Praziquantel—Dermatitis—Triamcinolone—hematologic cancer	6.69e-05	0.000314	CcSEcCtD
Praziquantel—Vertigo—Doxorubicin—hematologic cancer	6.69e-05	0.000314	CcSEcCtD
Praziquantel—Anorexia—Methotrexate—hematologic cancer	6.69e-05	0.000314	CcSEcCtD
Praziquantel—Urticaria—Prednisone—hematologic cancer	6.67e-05	0.000313	CcSEcCtD
Praziquantel—Headache—Triamcinolone—hematologic cancer	6.65e-05	0.000313	CcSEcCtD
Praziquantel—Body temperature increased—Prednisone—hematologic cancer	6.63e-05	0.000312	CcSEcCtD
Praziquantel—Abdominal pain—Prednisone—hematologic cancer	6.63e-05	0.000312	CcSEcCtD
Praziquantel—Diarrhoea—Betamethasone—hematologic cancer	6.59e-05	0.00031	CcSEcCtD
Praziquantel—Diarrhoea—Dexamethasone—hematologic cancer	6.59e-05	0.00031	CcSEcCtD
Praziquantel—Convulsion—Doxorubicin—hematologic cancer	6.45e-05	0.000303	CcSEcCtD
Praziquantel—Nervous system disorder—Epirubicin—hematologic cancer	6.44e-05	0.000303	CcSEcCtD
Praziquantel—Musculoskeletal discomfort—Methotrexate—hematologic cancer	6.39e-05	0.0003	CcSEcCtD
Praziquantel—Skin disorder—Epirubicin—hematologic cancer	6.38e-05	0.0003	CcSEcCtD
Praziquantel—Dizziness—Dexamethasone—hematologic cancer	6.37e-05	0.0003	CcSEcCtD
Praziquantel—Dizziness—Betamethasone—hematologic cancer	6.37e-05	0.0003	CcSEcCtD
Praziquantel—Myalgia—Doxorubicin—hematologic cancer	6.34e-05	0.000298	CcSEcCtD
Praziquantel—Nausea—Triamcinolone—hematologic cancer	6.31e-05	0.000297	CcSEcCtD
Praziquantel—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	6.29e-05	0.000296	CcSEcCtD
Praziquantel—Discomfort—Doxorubicin—hematologic cancer	6.26e-05	0.000294	CcSEcCtD
Praziquantel—Anorexia—Epirubicin—hematologic cancer	6.26e-05	0.000294	CcSEcCtD
Praziquantel—Somnolence—Methotrexate—hematologic cancer	6.24e-05	0.000293	CcSEcCtD
Praziquantel—Hypersensitivity—Prednisone—hematologic cancer	6.18e-05	0.000291	CcSEcCtD
Praziquantel—Vomiting—Dexamethasone—hematologic cancer	6.13e-05	0.000288	CcSEcCtD
Praziquantel—Vomiting—Betamethasone—hematologic cancer	6.13e-05	0.000288	CcSEcCtD
Praziquantel—Decreased appetite—Methotrexate—hematologic cancer	6.1e-05	0.000287	CcSEcCtD
Praziquantel—Rash—Betamethasone—hematologic cancer	6.08e-05	0.000286	CcSEcCtD
Praziquantel—Rash—Dexamethasone—hematologic cancer	6.08e-05	0.000286	CcSEcCtD
Praziquantel—Dermatitis—Dexamethasone—hematologic cancer	6.07e-05	0.000285	CcSEcCtD
Praziquantel—Dermatitis—Betamethasone—hematologic cancer	6.07e-05	0.000285	CcSEcCtD
Praziquantel—Gastrointestinal disorder—Methotrexate—hematologic cancer	6.06e-05	0.000285	CcSEcCtD
Praziquantel—Fatigue—Methotrexate—hematologic cancer	6.05e-05	0.000284	CcSEcCtD
Praziquantel—Headache—Dexamethasone—hematologic cancer	6.04e-05	0.000284	CcSEcCtD
Praziquantel—Headache—Betamethasone—hematologic cancer	6.04e-05	0.000284	CcSEcCtD
Praziquantel—Asthenia—Prednisone—hematologic cancer	6.02e-05	0.000283	CcSEcCtD
Praziquantel—Musculoskeletal discomfort—Epirubicin—hematologic cancer	5.98e-05	0.000281	CcSEcCtD
Praziquantel—Nervous system disorder—Doxorubicin—hematologic cancer	5.96e-05	0.00028	CcSEcCtD
Praziquantel—Pruritus—Prednisone—hematologic cancer	5.94e-05	0.000279	CcSEcCtD
Praziquantel—Skin disorder—Doxorubicin—hematologic cancer	5.9e-05	0.000277	CcSEcCtD
Praziquantel—Somnolence—Epirubicin—hematologic cancer	5.84e-05	0.000274	CcSEcCtD
Praziquantel—Anorexia—Doxorubicin—hematologic cancer	5.79e-05	0.000272	CcSEcCtD
Praziquantel—Feeling abnormal—Methotrexate—hematologic cancer	5.78e-05	0.000272	CcSEcCtD
Praziquantel—Diarrhoea—Prednisone—hematologic cancer	5.74e-05	0.00027	CcSEcCtD
Praziquantel—Gastrointestinal pain—Methotrexate—hematologic cancer	5.74e-05	0.00027	CcSEcCtD
Praziquantel—Nausea—Betamethasone—hematologic cancer	5.72e-05	0.000269	CcSEcCtD
Praziquantel—Nausea—Dexamethasone—hematologic cancer	5.72e-05	0.000269	CcSEcCtD
Praziquantel—Decreased appetite—Epirubicin—hematologic cancer	5.71e-05	0.000268	CcSEcCtD
Praziquantel—Gastrointestinal disorder—Epirubicin—hematologic cancer	5.67e-05	0.000266	CcSEcCtD
Praziquantel—Fatigue—Epirubicin—hematologic cancer	5.66e-05	0.000266	CcSEcCtD
Praziquantel—Urticaria—Methotrexate—hematologic cancer	5.57e-05	0.000262	CcSEcCtD
Praziquantel—Dizziness—Prednisone—hematologic cancer	5.55e-05	0.000261	CcSEcCtD
Praziquantel—Body temperature increased—Methotrexate—hematologic cancer	5.54e-05	0.000261	CcSEcCtD
Praziquantel—Abdominal pain—Methotrexate—hematologic cancer	5.54e-05	0.000261	CcSEcCtD
Praziquantel—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	5.53e-05	0.00026	CcSEcCtD
Praziquantel—Feeling abnormal—Epirubicin—hematologic cancer	5.41e-05	0.000254	CcSEcCtD
Praziquantel—Somnolence—Doxorubicin—hematologic cancer	5.4e-05	0.000254	CcSEcCtD
Praziquantel—Gastrointestinal pain—Epirubicin—hematologic cancer	5.37e-05	0.000252	CcSEcCtD
Praziquantel—Vomiting—Prednisone—hematologic cancer	5.34e-05	0.000251	CcSEcCtD
Praziquantel—Rash—Prednisone—hematologic cancer	5.29e-05	0.000249	CcSEcCtD
Praziquantel—Dermatitis—Prednisone—hematologic cancer	5.29e-05	0.000248	CcSEcCtD
Praziquantel—Decreased appetite—Doxorubicin—hematologic cancer	5.28e-05	0.000248	CcSEcCtD
Praziquantel—Headache—Prednisone—hematologic cancer	5.26e-05	0.000247	CcSEcCtD
Praziquantel—Gastrointestinal disorder—Doxorubicin—hematologic cancer	5.24e-05	0.000246	CcSEcCtD
Praziquantel—Fatigue—Doxorubicin—hematologic cancer	5.24e-05	0.000246	CcSEcCtD
Praziquantel—Urticaria—Epirubicin—hematologic cancer	5.21e-05	0.000245	CcSEcCtD
Praziquantel—Body temperature increased—Epirubicin—hematologic cancer	5.19e-05	0.000244	CcSEcCtD
Praziquantel—Abdominal pain—Epirubicin—hematologic cancer	5.19e-05	0.000244	CcSEcCtD
Praziquantel—Hypersensitivity—Methotrexate—hematologic cancer	5.17e-05	0.000243	CcSEcCtD
Praziquantel—Asthenia—Methotrexate—hematologic cancer	5.03e-05	0.000237	CcSEcCtD
Praziquantel—Feeling abnormal—Doxorubicin—hematologic cancer	5.01e-05	0.000235	CcSEcCtD
Praziquantel—Nausea—Prednisone—hematologic cancer	4.99e-05	0.000234	CcSEcCtD
Praziquantel—Gastrointestinal pain—Doxorubicin—hematologic cancer	4.97e-05	0.000233	CcSEcCtD
Praziquantel—Pruritus—Methotrexate—hematologic cancer	4.96e-05	0.000233	CcSEcCtD
Praziquantel—Hypersensitivity—Epirubicin—hematologic cancer	4.84e-05	0.000227	CcSEcCtD
Praziquantel—Urticaria—Doxorubicin—hematologic cancer	4.82e-05	0.000227	CcSEcCtD
Praziquantel—Abdominal pain—Doxorubicin—hematologic cancer	4.8e-05	0.000226	CcSEcCtD
Praziquantel—Body temperature increased—Doxorubicin—hematologic cancer	4.8e-05	0.000226	CcSEcCtD
Praziquantel—Diarrhoea—Methotrexate—hematologic cancer	4.8e-05	0.000226	CcSEcCtD
Praziquantel—Asthenia—Epirubicin—hematologic cancer	4.71e-05	0.000221	CcSEcCtD
Praziquantel—Pruritus—Epirubicin—hematologic cancer	4.64e-05	0.000218	CcSEcCtD
Praziquantel—Dizziness—Methotrexate—hematologic cancer	4.64e-05	0.000218	CcSEcCtD
Praziquantel—Diarrhoea—Epirubicin—hematologic cancer	4.49e-05	0.000211	CcSEcCtD
Praziquantel—Hypersensitivity—Doxorubicin—hematologic cancer	4.47e-05	0.00021	CcSEcCtD
Praziquantel—Vomiting—Methotrexate—hematologic cancer	4.46e-05	0.00021	CcSEcCtD
Praziquantel—Rash—Methotrexate—hematologic cancer	4.42e-05	0.000208	CcSEcCtD
Praziquantel—Dermatitis—Methotrexate—hematologic cancer	4.42e-05	0.000208	CcSEcCtD
Praziquantel—Headache—Methotrexate—hematologic cancer	4.39e-05	0.000207	CcSEcCtD
Praziquantel—Asthenia—Doxorubicin—hematologic cancer	4.36e-05	0.000205	CcSEcCtD
Praziquantel—Dizziness—Epirubicin—hematologic cancer	4.34e-05	0.000204	CcSEcCtD
Praziquantel—Pruritus—Doxorubicin—hematologic cancer	4.3e-05	0.000202	CcSEcCtD
Praziquantel—Vomiting—Epirubicin—hematologic cancer	4.17e-05	0.000196	CcSEcCtD
Praziquantel—Nausea—Methotrexate—hematologic cancer	4.17e-05	0.000196	CcSEcCtD
Praziquantel—Diarrhoea—Doxorubicin—hematologic cancer	4.16e-05	0.000195	CcSEcCtD
Praziquantel—Rash—Epirubicin—hematologic cancer	4.14e-05	0.000195	CcSEcCtD
Praziquantel—Dermatitis—Epirubicin—hematologic cancer	4.13e-05	0.000194	CcSEcCtD
Praziquantel—Headache—Epirubicin—hematologic cancer	4.11e-05	0.000193	CcSEcCtD
Praziquantel—Dizziness—Doxorubicin—hematologic cancer	4.02e-05	0.000189	CcSEcCtD
Praziquantel—Nausea—Epirubicin—hematologic cancer	3.9e-05	0.000183	CcSEcCtD
Praziquantel—Vomiting—Doxorubicin—hematologic cancer	3.86e-05	0.000181	CcSEcCtD
Praziquantel—Rash—Doxorubicin—hematologic cancer	3.83e-05	0.00018	CcSEcCtD
Praziquantel—Dermatitis—Doxorubicin—hematologic cancer	3.83e-05	0.00018	CcSEcCtD
Praziquantel—Headache—Doxorubicin—hematologic cancer	3.8e-05	0.000179	CcSEcCtD
Praziquantel—Nausea—Doxorubicin—hematologic cancer	3.61e-05	0.00017	CcSEcCtD
Praziquantel—CYP3A5—Metabolism—NUP98—hematologic cancer	6.55e-06	0.0003	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	6.51e-06	0.000298	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—MTAP—hematologic cancer	6.49e-06	0.000297	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—ARNTL—hematologic cancer	6.49e-06	0.000297	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—HDC—hematologic cancer	6.44e-06	0.000295	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—CYCS—hematologic cancer	6.4e-06	0.000293	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—HSP90AA1—hematologic cancer	6.36e-06	0.000291	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—ADCY7—hematologic cancer	6.36e-06	0.000291	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—NCOA3—hematologic cancer	6.36e-06	0.000291	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—IDH2—hematologic cancer	6.35e-06	0.000291	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—HMMR—hematologic cancer	6.35e-06	0.000291	CbGpPWpGaD
Praziquantel—CYP3A43—Metabolism—PTEN—hematologic cancer	6.33e-06	0.00029	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—NUP214—hematologic cancer	6.32e-06	0.000289	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—ACP5—hematologic cancer	6.31e-06	0.000289	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—CA9—hematologic cancer	6.31e-06	0.000289	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—NCOR2—hematologic cancer	6.23e-06	0.000285	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—ABCG2—hematologic cancer	6.19e-06	0.000283	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—MTR—hematologic cancer	6.19e-06	0.000283	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—ENO2—hematologic cancer	6.07e-06	0.000278	CbGpPWpGaD
Praziquantel—CYP3A43—Metabolism—EP300—hematologic cancer	6.04e-06	0.000276	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—ARNTL—hematologic cancer	5.97e-06	0.000273	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—IDH1—hematologic cancer	5.94e-06	0.000272	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—CDA—hematologic cancer	5.89e-06	0.00027	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—GSTT1—hematologic cancer	5.89e-06	0.000269	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—GSTO1—hematologic cancer	5.87e-06	0.000269	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—ABCC3—hematologic cancer	5.87e-06	0.000269	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—TXN—hematologic cancer	5.87e-06	0.000269	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—CA9—hematologic cancer	5.81e-06	0.000266	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—ACP5—hematologic cancer	5.81e-06	0.000266	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—FHL2—hematologic cancer	5.78e-06	0.000265	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—SDC1—hematologic cancer	5.75e-06	0.000263	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—SPHK1—hematologic cancer	5.74e-06	0.000263	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—NCOR2—hematologic cancer	5.73e-06	0.000262	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—AGRN—hematologic cancer	5.67e-06	0.00026	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—PC—hematologic cancer	5.67e-06	0.00026	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—GSTP1—hematologic cancer	5.64e-06	0.000258	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—UGT1A1—hematologic cancer	5.52e-06	0.000253	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—GBA—hematologic cancer	5.48e-06	0.000251	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—SLC35B2—hematologic cancer	5.48e-06	0.000251	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—IDH1—hematologic cancer	5.46e-06	0.00025	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—ABCC3—hematologic cancer	5.4e-06	0.000247	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—TXN—hematologic cancer	5.4e-06	0.000247	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—GSTO1—hematologic cancer	5.4e-06	0.000247	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—IDH2—hematologic cancer	5.38e-06	0.000246	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—HMMR—hematologic cancer	5.38e-06	0.000246	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—CRABP1—hematologic cancer	5.37e-06	0.000246	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—SLC22A1—hematologic cancer	5.37e-06	0.000246	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—ABCB1—hematologic cancer	5.34e-06	0.000245	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—SPHK1—hematologic cancer	5.28e-06	0.000242	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—ALOX5—hematologic cancer	5.23e-06	0.000239	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—GSTM1—hematologic cancer	5.19e-06	0.000237	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—NCOR1—hematologic cancer	5.19e-06	0.000237	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—UGT1A1—hematologic cancer	5.08e-06	0.000232	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	5.07e-06	0.000232	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—NUP98—hematologic cancer	5.07e-06	0.000232	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—ARNTL—hematologic cancer	5.06e-06	0.000231	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—MTAP—hematologic cancer	5.01e-06	0.000229	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—SLC22A1—hematologic cancer	4.94e-06	0.000226	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—CRABP1—hematologic cancer	4.94e-06	0.000226	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—CA9—hematologic cancer	4.92e-06	0.000225	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—ACP5—hematologic cancer	4.92e-06	0.000225	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—ADCY7—hematologic cancer	4.92e-06	0.000225	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—NCOA3—hematologic cancer	4.92e-06	0.000225	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—NQO1—hematologic cancer	4.89e-06	0.000224	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—CD44—hematologic cancer	4.89e-06	0.000224	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—NUP214—hematologic cancer	4.88e-06	0.000224	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—NCOR2—hematologic cancer	4.85e-06	0.000222	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	4.83e-06	0.000221	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—ALOX5—hematologic cancer	4.81e-06	0.00022	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—ABCG2—hematologic cancer	4.78e-06	0.000219	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—MTR—hematologic cancer	4.78e-06	0.000219	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—ENO2—hematologic cancer	4.69e-06	0.000215	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—NUP98—hematologic cancer	4.66e-06	0.000213	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—CYCS—hematologic cancer	4.63e-06	0.000212	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—IDH1—hematologic cancer	4.62e-06	0.000212	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—HSP90AA1—hematologic cancer	4.6e-06	0.00021	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—MTHFR—hematologic cancer	4.58e-06	0.00021	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—ABCC3—hematologic cancer	4.57e-06	0.000209	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—TXN—hematologic cancer	4.57e-06	0.000209	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—GSTO1—hematologic cancer	4.57e-06	0.000209	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—GSTT1—hematologic cancer	4.55e-06	0.000208	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—ADCY7—hematologic cancer	4.52e-06	0.000207	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—NCOA3—hematologic cancer	4.52e-06	0.000207	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—NUP214—hematologic cancer	4.49e-06	0.000206	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	4.48e-06	0.000205	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—SPHK1—hematologic cancer	4.47e-06	0.000205	CbGpPWpGaD
Praziquantel—CYP3A43—Metabolism—PIK3CA—hematologic cancer	4.47e-06	0.000204	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—FHL2—hematologic cancer	4.46e-06	0.000204	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—SDC1—hematologic cancer	4.45e-06	0.000204	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—ABCG2—hematologic cancer	4.4e-06	0.000201	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—MTR—hematologic cancer	4.4e-06	0.000201	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—AGRN—hematologic cancer	4.38e-06	0.0002	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—ENO2—hematologic cancer	4.32e-06	0.000198	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—UGT1A1—hematologic cancer	4.3e-06	0.000197	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	4.25e-06	0.000194	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	4.19e-06	0.000192	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—GSTT1—hematologic cancer	4.19e-06	0.000192	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—SLC22A1—hematologic cancer	4.18e-06	0.000191	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—CRABP1—hematologic cancer	4.18e-06	0.000191	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—HMMR—hematologic cancer	4.15e-06	0.00019	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—IDH2—hematologic cancer	4.15e-06	0.00019	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—SDC1—hematologic cancer	4.09e-06	0.000187	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—GSTP1—hematologic cancer	4.08e-06	0.000187	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—ALOX5—hematologic cancer	4.08e-06	0.000187	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	4.01e-06	0.000184	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—NUP98—hematologic cancer	3.95e-06	0.000181	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—ARNTL—hematologic cancer	3.9e-06	0.000179	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—ABCB1—hematologic cancer	3.86e-06	0.000177	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—PIK3CG—hematologic cancer	3.85e-06	0.000176	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—ADCY7—hematologic cancer	3.83e-06	0.000175	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—NCOA3—hematologic cancer	3.83e-06	0.000175	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—NUP214—hematologic cancer	3.8e-06	0.000174	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—CA9—hematologic cancer	3.8e-06	0.000174	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—ACP5—hematologic cancer	3.8e-06	0.000174	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—NQO1—hematologic cancer	3.78e-06	0.000173	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—CD44—hematologic cancer	3.78e-06	0.000173	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	3.77e-06	0.000172	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—GSTM1—hematologic cancer	3.75e-06	0.000172	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—NCOR1—hematologic cancer	3.75e-06	0.000172	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—NCOR2—hematologic cancer	3.75e-06	0.000171	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—MTR—hematologic cancer	3.73e-06	0.000171	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—ABCG2—hematologic cancer	3.73e-06	0.000171	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	3.7e-06	0.000169	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—ENO2—hematologic cancer	3.66e-06	0.000167	CbGpPWpGaD
Praziquantel—CYP3A43—Metabolism—AKT1—hematologic cancer	3.65e-06	0.000167	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—CYCS—hematologic cancer	3.58e-06	0.000164	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—CREBBP—hematologic cancer	3.57e-06	0.000163	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—IDH1—hematologic cancer	3.57e-06	0.000163	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—HSP90AA1—hematologic cancer	3.56e-06	0.000163	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—GSTT1—hematologic cancer	3.55e-06	0.000162	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—TXN—hematologic cancer	3.53e-06	0.000162	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—GSTO1—hematologic cancer	3.53e-06	0.000162	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—ABCC3—hematologic cancer	3.53e-06	0.000162	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	3.49e-06	0.00016	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—CD44—hematologic cancer	3.48e-06	0.000159	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—NQO1—hematologic cancer	3.48e-06	0.000159	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—SDC1—hematologic cancer	3.47e-06	0.000159	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—SPHK1—hematologic cancer	3.45e-06	0.000158	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—PIK3CD—hematologic cancer	3.39e-06	0.000155	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—ALB—hematologic cancer	3.34e-06	0.000153	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—UGT1A1—hematologic cancer	3.32e-06	0.000152	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—MTHFR—hematologic cancer	3.31e-06	0.000152	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	3.31e-06	0.000152	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—CYCS—hematologic cancer	3.29e-06	0.000151	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	3.27e-06	0.00015	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	3.27e-06	0.00015	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—SLC22A1—hematologic cancer	3.23e-06	0.000148	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—CRABP1—hematologic cancer	3.23e-06	0.000148	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.2e-06	0.000146	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—PIK3R1—hematologic cancer	3.2e-06	0.000146	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—GSTP1—hematologic cancer	3.15e-06	0.000144	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—ALOX5—hematologic cancer	3.15e-06	0.000144	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	3.13e-06	0.000143	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.05e-06	0.00014	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—NUP98—hematologic cancer	3.05e-06	0.000139	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—ABCB1—hematologic cancer	2.99e-06	0.000137	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—ADCY7—hematologic cancer	2.96e-06	0.000135	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—NCOA3—hematologic cancer	2.96e-06	0.000135	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—PIK3CB—hematologic cancer	2.95e-06	0.000135	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—NQO1—hematologic cancer	2.95e-06	0.000135	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—CD44—hematologic cancer	2.95e-06	0.000135	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—NUP214—hematologic cancer	2.94e-06	0.000134	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—GSTP1—hematologic cancer	2.9e-06	0.000133	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—GSTM1—hematologic cancer	2.9e-06	0.000133	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—NCOR1—hematologic cancer	2.9e-06	0.000133	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	2.89e-06	0.000132	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—ABCG2—hematologic cancer	2.88e-06	0.000132	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—MTR—hematologic cancer	2.88e-06	0.000132	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—ENO2—hematologic cancer	2.82e-06	0.000129	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—CYCS—hematologic cancer	2.79e-06	0.000128	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—PIK3CG—hematologic cancer	2.78e-06	0.000127	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	2.77e-06	0.000127	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—ABCB1—hematologic cancer	2.75e-06	0.000126	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—GSTT1—hematologic cancer	2.74e-06	0.000125	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—SDC1—hematologic cancer	2.67e-06	0.000122	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—GSTM1—hematologic cancer	2.67e-06	0.000122	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—NCOR1—hematologic cancer	2.67e-06	0.000122	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—CREBBP—hematologic cancer	2.58e-06	0.000118	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—MTHFR—hematologic cancer	2.56e-06	0.000117	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—PTEN—hematologic cancer	2.55e-06	0.000117	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.49e-06	0.000114	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—GSTP1—hematologic cancer	2.46e-06	0.000112	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—PIK3CD—hematologic cancer	2.45e-06	0.000112	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—EP300—hematologic cancer	2.43e-06	0.000111	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—ALB—hematologic cancer	2.42e-06	0.000111	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.38e-06	0.000109	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—MTHFR—hematologic cancer	2.36e-06	0.000108	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—ABCB1—hematologic cancer	2.33e-06	0.000106	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—PIK3R1—hematologic cancer	2.31e-06	0.000106	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—CD44—hematologic cancer	2.27e-06	0.000104	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—NQO1—hematologic cancer	2.27e-06	0.000104	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—NCOR1—hematologic cancer	2.26e-06	0.000103	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—GSTM1—hematologic cancer	2.26e-06	0.000103	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.26e-06	0.000103	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—PIK3CG—hematologic cancer	2.15e-06	9.85e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—CYCS—hematologic cancer	2.15e-06	9.85e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	2.14e-06	9.79e-05	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—PIK3CB—hematologic cancer	2.13e-06	9.76e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—MTHFR—hematologic cancer	2e-06	9.14e-05	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—CREBBP—hematologic cancer	2e-06	9.13e-05	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—PIK3CG—hematologic cancer	1.98e-06	9.06e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—GSTP1—hematologic cancer	1.9e-06	8.68e-05	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—PIK3CD—hematologic cancer	1.89e-06	8.66e-05	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—ALB—hematologic cancer	1.87e-06	8.55e-05	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—PTEN—hematologic cancer	1.84e-06	8.44e-05	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—CREBBP—hematologic cancer	1.84e-06	8.4e-05	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—PIK3CA—hematologic cancer	1.8e-06	8.23e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—ABCB1—hematologic cancer	1.8e-06	8.22e-05	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—PIK3R1—hematologic cancer	1.79e-06	8.18e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.76e-06	8.05e-05	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—EP300—hematologic cancer	1.76e-06	8.05e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—NCOR1—hematologic cancer	1.74e-06	7.98e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—GSTM1—hematologic cancer	1.74e-06	7.98e-05	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—PIK3CD—hematologic cancer	1.74e-06	7.96e-05	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—ALB—hematologic cancer	1.72e-06	7.86e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—PIK3CG—hematologic cancer	1.68e-06	7.68e-05	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—PIK3CB—hematologic cancer	1.65e-06	7.55e-05	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—PIK3R1—hematologic cancer	1.64e-06	7.52e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—CREBBP—hematologic cancer	1.55e-06	7.12e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.54e-06	7.05e-05	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—PIK3CB—hematologic cancer	1.52e-06	6.94e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—PIK3CD—hematologic cancer	1.47e-06	6.75e-05	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—AKT1—hematologic cancer	1.47e-06	6.73e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—ALB—hematologic cancer	1.46e-06	6.66e-05	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—PTEN—hematologic cancer	1.43e-06	6.52e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—PIK3R1—hematologic cancer	1.39e-06	6.37e-05	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—EP300—hematologic cancer	1.36e-06	6.22e-05	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—PTEN—hematologic cancer	1.31e-06	6e-05	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—PIK3CA—hematologic cancer	1.3e-06	5.95e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.29e-06	5.92e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—PIK3CB—hematologic cancer	1.29e-06	5.88e-05	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—EP300—hematologic cancer	1.25e-06	5.72e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.2e-06	5.49e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.14e-06	5.21e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—ALB—hematologic cancer	1.12e-06	5.14e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—PTEN—hematologic cancer	1.11e-06	5.08e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.07e-06	4.92e-05	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—AKT1—hematologic cancer	1.06e-06	4.86e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—EP300—hematologic cancer	1.06e-06	4.85e-05	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—PIK3CA—hematologic cancer	1.01e-06	4.6e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—PIK3CB—hematologic cancer	9.92e-07	4.54e-05	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—PIK3CA—hematologic cancer	9.25e-07	4.23e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—PTEN—hematologic cancer	8.57e-07	3.92e-05	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—AKT1—hematologic cancer	8.21e-07	3.76e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—EP300—hematologic cancer	8.17e-07	3.74e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—PIK3CA—hematologic cancer	7.83e-07	3.59e-05	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—AKT1—hematologic cancer	7.55e-07	3.46e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—AKT1—hematologic cancer	6.4e-07	2.93e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—PIK3CA—hematologic cancer	6.05e-07	2.77e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—AKT1—hematologic cancer	4.94e-07	2.26e-05	CbGpPWpGaD
